Cargando…
Modelling time‐course relationships with multiple treatments: Model‐based network meta‐analysis for continuous summary outcomes
BACKGROUND: Model‐based meta‐analysis (MBMA) is increasingly used to inform drug‐development decisions by synthesising results from multiple studies to estimate treatment, dose‐response, and time‐course characteristics. Network meta‐analysis (NMA) is used in Health Technology Appraisals for simultan...
Autores principales: | Pedder, Hugo, Dias, Sofia, Bennetts, Margherita, Boucher, Martin, Welton, Nicky J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563489/ https://www.ncbi.nlm.nih.gov/pubmed/31013000 http://dx.doi.org/10.1002/jrsm.1351 |
Ejemplares similares
-
Joining the Dots: Linking Disconnected Networks of Evidence Using Dose-Response Model-Based Network Meta-Analysis
por: Pedder, Hugo, et al.
Publicado: (2021) -
Model‐Based Network Meta‐Analysis: A Framework for Evidence Synthesis of Clinical Trial Data
por: Mawdsley, D, et al.
Publicado: (2016) -
Many Flavors of Model‐Based Meta‐Analysis: Part II – Modeling Summary Level Longitudinal Responses
por: Boucher, Martin, et al.
Publicado: (2018) -
Shared parameter model for competing risks and different data summaries in meta‐analysis: Implications for common and rare outcomes
por: Thom, Howard, et al.
Publicado: (2019) -
Automated generation of node‐splitting models for assessment of inconsistency in network meta‐analysis
por: van Valkenhoef, Gert, et al.
Publicado: (2015)